Emilio Lopez, MD
Vascular & Interventional Radiology · Lake Worth, FLNPI 1881919124
Payments from drug & device makers
What this record shows
This record is dominated by other: $20,500 of the $27,936 with a category attached, or 73.4%. Angiodynamics, Inc. accounts for 74.4% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2024 at $21,289 and has fallen 97.7% since, to $493 in 2025.
Across 249 payments — averaging $112.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$21K
- Cook Medical LLC$3K
- Philips North America LLC$1K
- Penumbra, Inc.$846
- Musculoskeletal Transplant Foundation Inc.$334
- Asahi Intecc USA, Inc.$321
- plus $1K from 14 others
Across 1 payment — averaging $16,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$16K
What the payments were for
- Food & beverage$7,43627%
- Other$20,50073%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 9 | $20,781 |
| Cook Medical LLC | 121 | $3,155 |
| Philips North America LLC | 44 | $1,252 |
| Penumbra, Inc. | 18 | $846 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $334 |
| Asahi Intecc USA, Inc. | 7 | $321 |
| Bard Peripheral Vascular, Inc. | 6 | $195 |
| Medtronic(2 entities) | 7 | $139 |
| Integra Lifesciences Corporation | 1 | $120 |
| W. L. Gore & Associates, Inc. | 3 | $119 |
| Cardiovascular Systems Inc. | 8 | $117 |
| Boston Scientific | 4 | $113 |
| Medela LLC | 6 | $98 |
| Cardiva Medical, Inc. | 2 | $76 |
| Inari Medical, Inc. | 2 | $67 |
| Cordis US CORP. | 3 | $63 |
| Johnson & Johnson | 3 | $58 |
| Bolton Medical Inc | 1 | $34 |
| Pacira Pharmaceuticals Incorporated | 1 | $33 |
| Siemens Medical Solutions USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$20,628
- Zilver PTX$461
- INTEGRA$360
- Indigo System$291
- Indigo$246
- Cook Medical Zilver PTX$223
- Stellarex$122
- INTEGRA DERMAL REGENERATION TEMPLATE$120
- PRIMATRIX$120
- Cook Medical Celect Platinum$117
- (6582) Visions 035$114
- VENOVO$113
- (4067) Tack Endo Sys BTK$112
- Cook Medical Zilver$108
- ASAHI PTCA Guide Wire$107
- Torcon NB$105
- Zilver Vena$100
How this compares
$27,936 in reported general payments places this provider in the 80th percentile of 329 vascular & interventional radiology providers in Florida.
See all vascular & interventional radiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 53 | $31,906 |
| BrilintaTicagrelor | 34 | $18,921 |
| ClopidogrelClopidogrel Bisulfate | 190 | $1,578 |
| Tolterodine Tartrate ErTolterodine Tartrate | 24 | $414 |
| Ciprofloxacin Hcl | 56 | $255 |
| Cilostazol | 19 | $215 |
| Cephalexin | 16 | $50 |
| Naproxen | 16 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $58 | $31,90653 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 329 vascular & interventional radiology providers in Florida.
Other vascular & interventional radiology in Lake Worth
- Stephen LeschakLake Worth$42K
- Ripal GandhiMiami$2.5M
- Michael CohnHollywood$1.3M
- Bret WiechmannGainesville$1.3M
- George OliveiraMiami$666K
- Fakhir ElmasriLakeland$563K
- Shaun PatelCoral Gables$458K
- Justin LeeTampa$408K
- Timothy YatesMiami Beach$392K
- Rishi RazdanJacksonville$378K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.